Alessandro Candreva MD PhD

New insights from #PROSPECTII substudy of non-culprit lesions post #cvAMI found that both physiologically sig & even non-physiologically sig lesions demonstrated a moderate-to-high presence of high-risk plaque jacc.org/doi/10.1016/j.… @GreggWStone @Kketina #JACCIMG #cvImaging

@DrBIqbal @KPujdak @AGIKinterv @PCRonline @CMichaelGibson @ateap0tist @Obisht @vlad_sok "trapping ballon in GE", thanks never heard of it

Top 🔟 Clinical Trials of 2024: 🔥 PREVENT 🔥 DanGer Shock 🔥 REDUCE-AMI 🔥 CLEAR SYNERGY (OASIS 9) 🔥 And more! Read the details of the clinical trials here: bit.ly/41Kb7nn

New @Nature A mechanism for why durable weight loss is so difficult: epigenetic memory of fat cells nature.com/articles/s4158… @vonMeyenn @laurahinte

"Is there a doctor on the plane?"✈️🩺 Responding to in-flight medical emergencies. #MedTwitter

Have we come a long way in treating acute myocardial infarction? Perusing the recommendations of the 1978 Harrison's Principles of Internal Medicine will leave you appalled! futurelearn.com/courses/artifi… @FutureLearn

Please 🙏🏻 repost @OSTOLab1 @ProfPaulEvans @PaneniLab @KralerSimon @BettinaHeideck1 @alecandreva @BarteltLab @MassiRuscica @society_eas @EAPCPresident @AboyansV @BNordestgaard @Metabolcenter

New #JACCAsia state-of-the-art comprehensive review on updated clinical data of intravascular imaging–guided #PCI and #IVUS/OCT-derived stent optimization criteria in Asia. bit.ly/3MxQz8I #ACCIntl

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC #ESCardio

In MATTERHORN, among patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral-valve surgery with respect to a composite of death, rehospitalization for heart failure, stroke, reintervention, or implantation of an assist device in the left ventricle at 1 year. Small trial, large noninferiority margin, less events than anticipated in the sample size assumption. #ESCCongress nejm.org/doi/full/10.10…

Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B. This represent a paradigm shift in the diagnosis and treatment of these patients.

Measurement & interpretation of hemodynamic data are integral aspects of treating patients w/ #HeartFailure. Read the key points from a state-of-the-art review on practical guidance for hemodynamic assessment by RHC in the management of HF. 🔗 bit.ly/4cHMr0S #JACCHF

Great study from @MatthEberhard @mergen_v @alecandreva @rengadr @rmanka_ and others from @RadiologieUSZ and @CardioZurich @JACCJournals ⬇️⬇️⬇️⬇️⬇️⬇️

Congratulations to @BarbaraStahli from the @CardioZurich and @CTECresearch on winning the Georg Friedrich Götz Prize 🏆 for outstanding internationally recognized achievement! #MULTISTARS @Unispital_USZ @UZH_en #FrankRuschitzka @FrancescoPaneni @ErsozluSara @ODzemali @PaneniLab

Must-read review on the epidemiology and burden of heart failure in Asia in the latest issue of JACC: Asia. Highlights: • In Asia, comprehensive data regarding the epidemiology and burden of HF remain limited. • This review summarizes the occurrence, causes, outcomes, and management of HF in Asia, from both the GBD data and registry studies. • HF remains a serious public health problem in Asia with significant regional variation; thus, strengthening the prevention and standardized management of HF in Asia is urgently needed. jacc.org/doi/10.1016/j.… @JACCJournals

In-vivo virtual noncalcium with #photoncounting #yesCCT -> Improved stenosis grading on noncalcium images Fantastic collaboration with ccm.mc shorturl.at/int07 @mergen_v @MatthEberhard @rmanka_ @alecandreva @rengadr @CardioZurich @RadiologieUSZ

The 7 best TED Talks I've ever seen: 🔖10/10 would Bookmark:

Why Does a Cardiologist Believe in a Therapy? The Role of Intuitiveness and Understanding the Mechanism ahajournals.org/doi/10.1161/CI…

Coronary computed tomographic angiography (CCTA), often combined with FFRCT, is emerging as the primary tool for diagnosing coronary artery disease, assessing hemodynamic impact, and guiding revascularization planning. It effectively rules out atherosclerosis, monitors plaque progression, and evaluates non-obstructive ischemia. In cases of significant obstruction, CCTA aids in determining disease complexity and optimizes intervention strategies, including stent or graft placement. ow.ly/GLAv50Qv4nh

February 22 and 23, 2024 What is it? It is the appointment you don’t wanna miss if you’re interested in 💪🏻 challenging CHIPs 💥 calcium modification 📸 intracoronary imaging Come join us in Lucerne if you want 🔥 debates 🔝discussions 🆒 workshops luks.ch/veranstaltunge…